• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续性甲硝唑诱发的周围神经病变。

Persistent metronidazole-induced peripheral neuropathy.

作者信息

Boyce E G, Cookson E T, Bond W S

机构信息

Department of Pharmacy Practice and Pharmacy Administration, Philadelphia College of Pharmacy and Science, PA 19104.

出版信息

DICP. 1990 Jan;24(1):19-21. doi: 10.1177/106002809002400103.

DOI:10.1177/106002809002400103
PMID:2154078
Abstract

We report the case of a young woman with Crohn's disease who developed a debilitating peripheral neuropathy when treated with metronidazole 2000 mg/d for 50 days. The patient's neuropathy improved considerably after the discontinuation of metronidazole, but still persists two years later. The current literature on this topic is reviewed. Reports such as this one underscore the need to closely monitor the neurologic status of patients undergoing chronic treatment with metronidazole.

摘要

我们报告了一例患有克罗恩病的年轻女性病例,该患者在接受每日2000毫克甲硝唑治疗50天后出现了使人衰弱的周围神经病变。停用甲硝唑后,患者的神经病变有了显著改善,但两年后仍持续存在。本文对该主题的现有文献进行了综述。像这样的报告强调了密切监测接受甲硝唑慢性治疗患者神经状态的必要性。

相似文献

1
Persistent metronidazole-induced peripheral neuropathy.持续性甲硝唑诱发的周围神经病变。
DICP. 1990 Jan;24(1):19-21. doi: 10.1177/106002809002400103.
2
Peripheral neuropathy in Crohn's disease patients treated with metronidazole.接受甲硝唑治疗的克罗恩病患者的周围神经病变。
Gastroenterology. 1985 Mar;88(3):681-4. doi: 10.1016/0016-5085(85)90137-4.
3
Metronidazole neuropathy.甲硝唑神经病变
Br Med J. 1977 Sep 3;2(6087):610-1. doi: 10.1136/bmj.2.6087.610.
4
Metronidazole neuropathy.甲硝唑神经病变
J Neurol Neurosurg Psychiatry. 1976 Apr;39(4):403-5. doi: 10.1136/jnnp.39.4.403.
5
Neurophysiologic studies of patients with Crohn's disease on long-term treatment with metronidazole.
Scand J Gastroenterol. 1991 Feb;26(2):219-24. doi: 10.3109/00365529109025034.
6
Metronidazole-induced acute pancreatitis.
Rev Infect Dis. 1991 Nov-Dec;13(6):1213-5. doi: 10.1093/clinids/13.6.1213.
7
[Metronidazole-induced reversible cerebellar lesions and peripheral neuropathy].[甲硝唑引起的可逆性小脑病变和周围神经病变]
Med Mal Infect. 2009 Dec;39(12):906-8. doi: 10.1016/j.medmal.2008.11.007. Epub 2008 Dec 31.
8
Healing of perineal Crohn's disease with metronidazole.甲硝唑治疗会阴克罗恩病的疗效观察
Gastroenterology. 1980 Aug;79(2):357-65.
9
The use of metronidazole (Flagyl) in Crohn's disease.甲硝唑(灭滴灵)在克罗恩病中的应用。
J Clin Gastroenterol. 1988 Oct;10(5):479-81. doi: 10.1097/00004836-198810000-00002.
10
Clinical relevance of metronidazole and peripheral neuropathy: a systematic review of the literature.甲硝唑与周围神经病变的临床相关性:文献系统评价。
Int J Antimicrob Agents. 2018 Mar;51(3):319-325. doi: 10.1016/j.ijantimicag.2017.08.033. Epub 2017 Sep 5.

引用本文的文献

1
Peripheral neuropathy and gastroenterologic disorders: an overview on an underrecognized association.周围神经病变与胃肠疾病:对一种未被充分认识的关联的概述
Acta Biomed. 2018 Dec 17;89(9-S):22-32. doi: 10.23750/abm.v89i9-S.7956.
2
Metronidazole-induced encephalopathy in a patient with Crohn's disease.一名克罗恩病患者的甲硝唑诱发的脑病
Intest Res. 2017 Jan;15(1):124-129. doi: 10.5217/ir.2017.15.1.124. Epub 2017 Jan 31.
3
Antibiotic-induced neurotoxicity.抗生素诱导的神经毒性。
Curr Infect Dis Rep. 2014 Dec;16(12):448. doi: 10.1007/s11908-014-0448-3.
4
Inflammatory bowel disease: an increased risk factor for neurologic complications.炎症性肠病:神经系统并发症的一个风险增加因素。
World J Gastroenterol. 2014 Feb 7;20(5):1228-37. doi: 10.3748/wjg.v20.i5.1228.
5
Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis.甲硝唑治疗肺部耐多药结核病的疗效和安全性。
Antimicrob Agents Chemother. 2013 Aug;57(8):3903-9. doi: 10.1128/AAC.00753-13. Epub 2013 Jun 3.
6
Inflammatory bowel disease: an increased risk factor for recurrent laryngeal nerve palsy in thyroid surgery.炎症性肠病:甲状腺手术中喉返神经麻痹复发的一个危险因素增加。
Acta Otorhinolaryngol Ital. 2012 Apr;32(2):130-2.